Optibrium Enters Cheminformatics Collaboration with MSD

Optibrium™, a developer of software for drug discovery, today announced a collaboration with MSD tradename of Merck & Co., Inc, Kenilworth NJ USA. As part of the collaboration, MSD has adopted Optibrium’s StarDrop™ software as a central component of their cheminformatics infrastructure.

The collaboration, between MSD and Optibrium, will include the integration of StarDrop with MSD’s in-house capabilities and the joint development of new tools, to improve cycle times, efficiency, and productivity of the drug discovery process.

We are delighted to enter this collaboration to contribute to MSD’s world-leading cheminformatics infrastructure. We look forward to working together to advance new tools based around StarDrop to further refine our compound design platform.”

Dr. Matthew Segall, Optibrium’s CEO

StarDrop is a complete package of fully integrated, elegant software for small molecule design, optimization, and data analysis. It supports researchers by quickly targeting high-quality chemistry in hit-to-lead and lead optimization. StarDrop’s unique approach to multi-parameter optimization combined with cutting-edge predictive modeling and generative chemistry capabilities helps to guide compound design decisions and will enable MSD’s researchers to explore new optimization strategies.

For further information on Optibrium and StarDrop, please visit https://optibrium.com/, contact [email protected] or call +44 1223 815900


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Optibrium Ltd.. (2023, March 11). Optibrium Enters Cheminformatics Collaboration with MSD. News-Medical. Retrieved on April 21, 2024 from https://www.news-medical.net/news/20201110/Optibrium-Enters-Cheminformatics-Collaboration-with-MSD.aspx.

  • MLA

    Optibrium Ltd.. "Optibrium Enters Cheminformatics Collaboration with MSD". News-Medical. 21 April 2024. <https://www.news-medical.net/news/20201110/Optibrium-Enters-Cheminformatics-Collaboration-with-MSD.aspx>.

  • Chicago

    Optibrium Ltd.. "Optibrium Enters Cheminformatics Collaboration with MSD". News-Medical. https://www.news-medical.net/news/20201110/Optibrium-Enters-Cheminformatics-Collaboration-with-MSD.aspx. (accessed April 21, 2024).

  • Harvard

    Optibrium Ltd.. 2023. Optibrium Enters Cheminformatics Collaboration with MSD. News-Medical, viewed 21 April 2024, https://www.news-medical.net/news/20201110/Optibrium-Enters-Cheminformatics-Collaboration-with-MSD.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Optibrium launches a metabolism prediction software platform tailored to DMPK scientists